NO2185155T3 - - Google Patents
Info
- Publication number
- NO2185155T3 NO2185155T3 NO08782602A NO08782602A NO2185155T3 NO 2185155 T3 NO2185155 T3 NO 2185155T3 NO 08782602 A NO08782602 A NO 08782602A NO 08782602 A NO08782602 A NO 08782602A NO 2185155 T3 NO2185155 T3 NO 2185155T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Pregnancy & Childbirth (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95369407P | 2007-08-03 | 2007-08-03 | |
| PCT/US2008/072066 WO2009020897A1 (en) | 2007-08-03 | 2008-08-04 | Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine recptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2185155T3 true NO2185155T3 (enExample) | 2018-03-03 |
Family
ID=40338740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO08782602A NO2185155T3 (enExample) | 2007-08-03 | 2008-08-04 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US20090036468A1 (enExample) |
| EP (1) | EP2185155B1 (enExample) |
| JP (1) | JP5460594B2 (enExample) |
| KR (1) | KR101612563B1 (enExample) |
| CN (1) | CN101815519B (enExample) |
| AU (1) | AU2008283989B2 (enExample) |
| CA (1) | CA2695519A1 (enExample) |
| CY (1) | CY1119828T1 (enExample) |
| DK (1) | DK2185155T3 (enExample) |
| EA (1) | EA018064B1 (enExample) |
| ES (1) | ES2653852T3 (enExample) |
| HR (1) | HRP20171908T1 (enExample) |
| HU (1) | HUE036004T2 (enExample) |
| LT (1) | LT2185155T (enExample) |
| MY (1) | MY157192A (enExample) |
| NO (1) | NO2185155T3 (enExample) |
| PL (1) | PL2185155T3 (enExample) |
| PT (1) | PT2185155T (enExample) |
| SI (1) | SI2185155T1 (enExample) |
| WO (1) | WO2009020897A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS53866B1 (sr) | 2008-07-16 | 2015-08-31 | Richter Gedeon Nyrt. | Farmaceutske formulacije koje sadrže ligande dopaminskih receptora |
| US20110117214A1 (en) * | 2009-11-16 | 2011-05-19 | Auspex Pharmaceuticals, Inc. | Cyclohexyl urea modulators of d2 receptors and/or d3 receptors |
| HUE031556T2 (en) | 2010-06-18 | 2017-07-28 | Altos Therapeutics Llc | D2 antagonists, methods of synthesis and methods of use |
| US8912197B2 (en) | 2012-08-20 | 2014-12-16 | Forest Laboratories Holdings Ltd. | Crystalline form of carbamoyl-cyclohexane derivatives |
| US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
| HUP1700253A1 (hu) * | 2017-06-13 | 2019-01-28 | Richter Gedeon Nyrt | Szilárd orális gyógyszerkészítmények |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
| HU231500B1 (hu) * | 2019-04-10 | 2024-04-28 | Richter Gedeon Nyrt | Karbamoil-ciklohexán származékok autizmus spektrum betegség kezelésére |
| US12377112B2 (en) | 2019-04-17 | 2025-08-05 | Compass Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
| US20230149392A1 (en) * | 2021-10-28 | 2023-05-18 | Abbvie Inc. | Treatment of major depressive disorder |
| EP4447948A1 (en) * | 2021-12-13 | 2024-10-23 | COMPASS Pathfinder Limited | Psilocybin and an adjunctive serotonin reuptake inhibitor for use in the treatment of treatment-resistant depression |
| AU2023234747A1 (en) * | 2022-03-17 | 2024-09-12 | Mapi Pharma Ltd. | Depot systems comprising cariprazine or salts thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
| ZA977967B (en) * | 1996-09-23 | 1999-03-04 | Lilly Co Eli | Combination therapy for treatment of psychoses |
| US6960577B2 (en) * | 1998-05-22 | 2005-11-01 | Eli Lilly And Company | Combination therapy for treatment of refractory depression |
| US6556540B1 (en) * | 1998-05-29 | 2003-04-29 | Paradyne Corporation | System and method for non-intrusive measurement of service quality in a communications network |
| HRP20020344B1 (hr) * | 1999-10-25 | 2010-10-31 | H. Lundbeck A/S | Način priprave citaloprama |
| UA77650C2 (en) * | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
| WO2002087566A1 (en) * | 2001-05-01 | 2002-11-07 | H. Lundbeck A/S | The use of enantiomeric pure escitalopram |
| AU2003235442A1 (en) * | 2002-04-12 | 2003-10-27 | Sepracor, Inc. | 3-aza- and 1,4-diaza-bicyclo(4.3.0)nonanes, and methods of use thereof |
| MXPA04012693A (es) * | 2002-06-20 | 2005-03-23 | Lundbeck & Co As H | Terapia de combinacion en donde se utiliza un inhibidor de recaptacion de serotonina. |
| HU227534B1 (en) * | 2003-08-04 | 2011-08-29 | Richter Gedeon Nyrt | (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them |
| EA200600531A1 (ru) * | 2003-09-04 | 2006-08-25 | Х. Лундбекк А/С | Сочетание ингибитора обратного захвата серотонина и локсапина |
| HUP0500170A3 (en) * | 2005-02-03 | 2007-11-28 | Richter Gedeon Nyrt | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them |
| TW200812993A (en) * | 2006-05-02 | 2008-03-16 | Lundbeck & Co As H | New uses of escitalopram |
| HU230748B1 (hu) * | 2007-05-11 | 2018-02-28 | Richter Gedeon Nyrt | Új piperazin só és előállítási eljárása |
-
2008
- 2008-08-04 US US12/185,211 patent/US20090036468A1/en not_active Abandoned
- 2008-08-04 MY MYPI2010000523A patent/MY157192A/en unknown
- 2008-08-04 AU AU2008283989A patent/AU2008283989B2/en active Active
- 2008-08-04 DK DK08782602.0T patent/DK2185155T3/en active
- 2008-08-04 LT LTEP08782602.0T patent/LT2185155T/lt unknown
- 2008-08-04 HU HUE08782602A patent/HUE036004T2/hu unknown
- 2008-08-04 KR KR1020107004638A patent/KR101612563B1/ko active Active
- 2008-08-04 CA CA2695519A patent/CA2695519A1/en not_active Abandoned
- 2008-08-04 ES ES08782602.0T patent/ES2653852T3/es active Active
- 2008-08-04 EP EP08782602.0A patent/EP2185155B1/en active Active
- 2008-08-04 PT PT87826020T patent/PT2185155T/pt unknown
- 2008-08-04 PL PL08782602T patent/PL2185155T3/pl unknown
- 2008-08-04 CN CN2008801062563A patent/CN101815519B/zh active Active
- 2008-08-04 SI SI200831900T patent/SI2185155T1/en unknown
- 2008-08-04 WO PCT/US2008/072066 patent/WO2009020897A1/en not_active Ceased
- 2008-08-04 JP JP2010520238A patent/JP5460594B2/ja active Active
- 2008-08-04 NO NO08782602A patent/NO2185155T3/no unknown
- 2008-08-04 HR HRP20171908TT patent/HRP20171908T1/hr unknown
- 2008-08-04 EA EA201000280A patent/EA018064B1/ru unknown
-
2010
- 2010-09-27 US US12/890,752 patent/US20110015208A1/en not_active Abandoned
-
2011
- 2011-10-10 US US13/269,928 patent/US20120028991A1/en not_active Abandoned
-
2017
- 2017-12-07 CY CY20171101293T patent/CY1119828T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA018064B1 (ru) | 2013-05-30 |
| KR20100059830A (ko) | 2010-06-04 |
| AU2008283989A1 (en) | 2009-02-12 |
| CY1119828T1 (el) | 2018-06-27 |
| HUE036004T2 (hu) | 2018-06-28 |
| ES2653852T3 (es) | 2018-02-09 |
| DK2185155T3 (en) | 2018-01-02 |
| EP2185155B1 (en) | 2017-10-04 |
| HK1144784A1 (en) | 2011-03-11 |
| US20110015208A1 (en) | 2011-01-20 |
| MY157192A (en) | 2016-05-13 |
| JP5460594B2 (ja) | 2014-04-02 |
| EA201000280A1 (ru) | 2010-08-30 |
| LT2185155T (lt) | 2017-12-11 |
| JP2010535790A (ja) | 2010-11-25 |
| PT2185155T (pt) | 2018-01-04 |
| PL2185155T3 (pl) | 2018-03-30 |
| EP2185155A1 (en) | 2010-05-19 |
| EP2185155A4 (en) | 2012-04-25 |
| US20120028991A1 (en) | 2012-02-02 |
| SI2185155T1 (en) | 2018-02-28 |
| CN101815519B (zh) | 2013-08-21 |
| CN101815519A (zh) | 2010-08-25 |
| HRP20171908T1 (hr) | 2018-01-26 |
| CA2695519A1 (en) | 2009-02-12 |
| WO2009020897A1 (en) | 2009-02-12 |
| KR101612563B1 (ko) | 2016-04-14 |
| AU2008283989B2 (en) | 2013-12-05 |
| US20090036468A1 (en) | 2009-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2185155T3 (enExample) | ||
| JP2009164732A5 (enExample) | ||
| CN300728420S (zh) | 套玉砂点玻璃片(小鱼片) | |
| CN300728481S (zh) | 按摩器(hq826) | |
| CN300732559S (zh) | 轮胎(c6577f) | |
| CN300732470S (zh) | 圣诞礼盒工艺品(园林1) | |
| CN300732463S (zh) | 饰物(长八角形万字型) | |
| CN300732437S (zh) | 装饰品(玻璃工艺盘ⅱ) | |
| CN300732047S (zh) | 包装罐(溪黄草茶) | |
| CN300731739S (zh) | 奶锅(sf系列) | |
| CN300731686S (zh) | 盒(dwb-8) | |
| CN300731653S (zh) | 被套(花之舞) | |
| CN300731296S (zh) | 压花布(j2908) | |
| CN300730819S (zh) | 蜡烛(163) | |
| CN300730798S (zh) | 蜡烛(200) | |
| CN300730636S (zh) | 烛台(156) | |
| CN300730635S (zh) | 烛台(45) | |
| CN300730356S (zh) | 瓶贴(米婆婆甜香酒酿原汁) | |
| CN300730249S (zh) | 修正带(7247) | |
| CN300729829S (zh) | 轮胎(花纹278) | |
| CN300729742S (zh) | 工艺画 | |
| CN300729704S (zh) | 首饰链(hy-an0035) | |
| CN300729664S (zh) | 测量仪表(16) | |
| CN300729634S (zh) | 桌钟(h1093) | |
| CN300729611S (zh) | 包装袋(久津源茗茶) |